Accuray Inc (ARAY)
1.745
-0.06
(-3.59%)
USD |
NASDAQ |
Nov 14, 16:00
1.85
+0.10
(+6.02%)
After-Hours: 20:00
Accuray Gross Profit (Annual): 142.92M for June 30, 2024
Gross Profit (Annual) Chart
Historical Gross Profit (Annual) Data
Date | Value |
---|---|
June 30, 2024 | 142.92M |
June 30, 2023 | 153.96M |
June 30, 2022 | 159.96M |
June 30, 2021 | 159.51M |
June 30, 2020 | 149.72M |
June 30, 2019 | 162.65M |
June 30, 2018 | 161.70M |
June 30, 2017 | 141.34M |
June 30, 2016 | 158.71M |
June 30, 2015 | 145.40M |
June 30, 2014 | 142.80M |
Date | Value |
---|---|
June 30, 2013 | 97.64M |
June 30, 2012 | 137.27M |
June 30, 2011 | 107.24M |
June 30, 2010 | 104.02M |
June 30, 2009 | 115.29M |
June 30, 2008 | 106.95M |
June 30, 2007 | 80.04M |
June 30, 2006 | 25.40M |
June 30, 2005 | 11.26M |
June 30, 2004 | |
June 30, 2003 | -0.317M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Annual) Range, Past 5 Years
142.92M
Minimum
2024
159.96M
Maximum
2022
153.21M
Average
153.96M
Median
2023
Gross Profit (Annual) Benchmarks
Boston Scientific Corp | 9.895B |
Baxter International Inc | 4.975B |
AngioDynamics Inc | 154.70M |
Masimo Corp | 1.004B |
Perspective Therapeutics Inc | -- |